FDA Developing Safety Research Agenda For Pediatric Anesthesia
This article was originally published in The Pink Sheet Daily
The Anesthetic and Life Support Drugs Advisory Committee will be asked to suggest a strategy that "complements the ongoing clinical and epidemiological studies."
You may also be interested in...
No organization acting by itself can hope to study the neurological risks of anesthesia in infants and young children, the agency says.
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.